Abstract: OBJECTIVES: To estimate the budget impact from the introduction of Ivosidenib for the treatment of patients with locally advanced or metastatic cholangiocarcinoma (CCA) with an IDH1 R132 mutation who were previously treated by at least one prior line of...
Abstract: OBJECTIVES: To investigate the budgetary impact of adopting epcoritamab for the recently indicated treatment of relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after at least two lines of systemic therapy in Greece. METHODS: A budget...
Abstract: OBJECTIVES: A recently published observational study, for the management of non-valvular atrial fibrillation (NVAF), suggests that switching from apixaban to rivaroxaban may be associated with higher risk for unfavorable outcomes. There is a lack of evidence...
Abstract:OBJECTIVES: To estimate the cost-effectiveness of foslevodopa/foscarbidopa, a 24-hour continuous subcutaneous infusion of levodopa-based therapy, compared to levodopa/carbidopa intestinal gel (LCIG), the most utilized device-aided therapy for the treatment of...
Abstract Background/Objectives: To evaluate the health benefits, costs, and cost-effectiveness of vaccination with bivalent respiratory syncytial virus stabilized prefusion F vaccine (RSVpreF) for the prevention of lower respiratory tract disease caused by respiratory...